Index by author

July 01 1999; volume 22 issue 7

A

  1. Adler, A I

    1. Lower-extremity amputation in diabetes. The independent effects of peripheral vascular disease, sensory neuropathy, and foot ulcers.
      A I Adler, E J Boyko, J H Ahroni and D G Smith
      Diabetes Care 1999 Jul; 22 (7): 1029-1035. https://doi.org/10.2337/diacare.22.7.1029

  2. Ahroni, J H

    1. Lower-extremity amputation in diabetes. The independent effects of peripheral vascular disease, sensory neuropathy, and foot ulcers.
      A I Adler, E J Boyko, J H Ahroni and D G Smith
      Diabetes Care 1999 Jul; 22 (7): 1029-1035. https://doi.org/10.2337/diacare.22.7.1029
    2. A prospective study of risk factors for diabetic foot ulcer. The Seattle Diabetic Foot Study.
      E J Boyko, J H Ahroni, V Stensel, R C Forsberg, D R Davignon and D G Smith
      Diabetes Care 1999 Jul; 22 (7): 1036-1042. https://doi.org/10.2337/diacare.22.7.1036

  3. Alvarsson, M

    1. Low birth weight, family history of diabetes, and glucose intolerance in Swedish middle-aged men.
      S Carlsson, P G Persson, M Alvarsson, S Efendic, A Norman, L Svanström, C G Ostenson and V Grill
      Diabetes Care 1999 Jul; 22 (7): 1043-1047. https://doi.org/10.2337/diacare.22.7.1043

B

  1. Bache, I

    1. Previous maternal abortion, longer gestation, and younger maternal age decrease the risk of type 1 diabetes among male offspring.
      I Bache, T Bock, A Vølund and K Buschard
      Diabetes Care 1999 Jul; 22 (7): 1063-1065. https://doi.org/10.2337/diacare.22.7.1063

  2. Bajaj, M

    1. Blood glucose awareness training and epinephrine responses to hypoglycemia during intensive treatment in type 1 diabetes.
      B T Kinsley, K Weinger, M Bajaj, C J Levy, D C Simonson, M Quigley, D J Cox and A M Jacobson
      Diabetes Care 1999 Jul; 22 (7): 1022-1028. https://doi.org/10.2337/diacare.22.7.1022

  3. Bakst, A W

    1. Type 2 diabetes: incremental medical care costs during the first 8 years after diagnosis.
      J B Brown, G A Nichols, H S Glauber and A W Bakst
      Diabetes Care 1999 Jul; 22 (7): 1116-1124. https://doi.org/10.2337/diacare.22.7.1116

  4. Bean, J A

    1. Is fasting leptin associated with insulin resistance among nondiabetic individuals? The Miami Community Health Study.
      R P Donahue, R J Prineas, R D Donahue, P Zimmet, J A Bean, M De Courten, G Collier, R B Goldberg, J S Skyler and N Schneiderman
      Diabetes Care 1999 Jul; 22 (7): 1092-1096. https://doi.org/10.2337/diacare.22.7.1092

  5. Becker, D

    1. Improved glycemic control reduces the impact of weight gain on cardiovascular risk factors in type 1 diabetes. The Epidemiology of Diabetes Complications Study.
      K V Williams, J R Erbey, D Becker and T J Orchard
      Diabetes Care 1999 Jul; 22 (7): 1084-1091. https://doi.org/10.2337/diacare.22.7.1084

  6. Berden, J H

    1. Prevalence of "syndrome X" features in parents of type 1 diabetic patients with or without nephropathy.
      B Verhage, G Vervoort, C Wolkotte, L D Elving, J F Wetzels, H Willems, P Smits, A L Verbeek and J H Berden
      Diabetes Care 1999 Jul; 22 (7): 1048-1052. https://doi.org/10.2337/diacare.22.7.1048

  7. Berg, T J

    1. Serum levels of advanced glycation end products are associated with left ventricular diastolic function in patients with type 1 diabetes.
      T J Berg, O Snorgaard, J Faber, P A Torjesen, P Hildebrandt, J Mehlsen and K F Hanssen
      Diabetes Care 1999 Jul; 22 (7): 1186-1190. https://doi.org/10.2337/diacare.22.7.1186

  8. Bierhaus, A

    1. alpha-Tocopherol induces leptin expression in healthy individuals and in vitro.
      B Isermann, A Bierhaus, H Tritschler, R Ziegler and P P Nawroth
      Diabetes Care 1999 Jul; 22 (7): 1227-1228. https://doi.org/10.2337/diacare.22.7.1227a

  9. Bloomgarden, Z T

    1. The European Association for the Study of Diabetes Annual Meeting, 1998. Treatment of type 2 diabetes and the pathogenesis of complications.
      Z T Bloomgarden
      Diabetes Care 1999 Jul; 22 (7): 1209-1215.

  10. Blum, W F

    1. Leptin and variables of body adiposity, energy balance, and insulin resistance in a population-based study. The Hoorn Study.
      J B Ruige, J M Dekker, W F Blum, C D Stehouwer, G Nijpels, J Mooy, P J Kostense, L M Bouter and R J Heine
      Diabetes Care 1999 Jul; 22 (7): 1097-1104. https://doi.org/10.2337/diacare.22.7.1097

  11. Bock, T

    1. Previous maternal abortion, longer gestation, and younger maternal age decrease the risk of type 1 diabetes among male offspring.
      I Bache, T Bock, A Vølund and K Buschard
      Diabetes Care 1999 Jul; 22 (7): 1063-1065. https://doi.org/10.2337/diacare.22.7.1063

  12. Bouter, L M

    1. Leptin and variables of body adiposity, energy balance, and insulin resistance in a population-based study. The Hoorn Study.
      J B Ruige, J M Dekker, W F Blum, C D Stehouwer, G Nijpels, J Mooy, P J Kostense, L M Bouter and R J Heine
      Diabetes Care 1999 Jul; 22 (7): 1097-1104. https://doi.org/10.2337/diacare.22.7.1097

  13. Boyko, E J

    1. Lower-extremity amputation in diabetes. The independent effects of peripheral vascular disease, sensory neuropathy, and foot ulcers.
      A I Adler, E J Boyko, J H Ahroni and D G Smith
      Diabetes Care 1999 Jul; 22 (7): 1029-1035. https://doi.org/10.2337/diacare.22.7.1029
    2. A prospective study of risk factors for diabetic foot ulcer. The Seattle Diabetic Foot Study.
      E J Boyko, J H Ahroni, V Stensel, R C Forsberg, D R Davignon and D G Smith
      Diabetes Care 1999 Jul; 22 (7): 1036-1042. https://doi.org/10.2337/diacare.22.7.1036

  14. Branch, D R

    1. High-dose vitamin C supplementation increases plasma glucose.
      D R Branch
      Diabetes Care 1999 Jul; 22 (7): 1218-1219. https://doi.org/10.2337/diacare.22.7.1218

  15. Brown, J B

    1. Type 2 diabetes: incremental medical care costs during the first 8 years after diagnosis.
      J B Brown, G A Nichols, H S Glauber and A W Bakst
      Diabetes Care 1999 Jul; 22 (7): 1116-1124. https://doi.org/10.2337/diacare.22.7.1116

  16. Brunzell, J D

    1. Increased small dense LDL and intermediate-density lipoprotein with albuminuria in type 1 diabetes.
      S D Sibley, J E Hokanson, M W Steffes, J Q Purnell, S M Marcovina, P A Cleary and J D Brunzell
      Diabetes Care 1999 Jul; 22 (7): 1165-1170. https://doi.org/10.2337/diacare.22.7.1165

  17. Buschard, K

    1. Previous maternal abortion, longer gestation, and younger maternal age decrease the risk of type 1 diabetes among male offspring.
      I Bache, T Bock, A Vølund and K Buschard
      Diabetes Care 1999 Jul; 22 (7): 1063-1065. https://doi.org/10.2337/diacare.22.7.1063

C

  1. Carlsson, S

    1. Low birth weight, family history of diabetes, and glucose intolerance in Swedish middle-aged men.
      S Carlsson, P G Persson, M Alvarsson, S Efendic, A Norman, L Svanström, C G Ostenson and V Grill
      Diabetes Care 1999 Jul; 22 (7): 1043-1047. https://doi.org/10.2337/diacare.22.7.1043

  2. Catino, M

    1. Increased Na+/Li+ countertransport activity may help to identify type 1 diabetic adolescents and young adults at risk for developing persistent microalbuminuria.
      F Chiarelli, M Catino, S Tumini, M de Martino, A Mezzetti, A Verrotti and M Vanelli
      Diabetes Care 1999 Jul; 22 (7): 1158-1164. https://doi.org/10.2337/diacare.22.7.1158

  3. Chambless, L E

    1. Prospective associations of fasting insulin, body fat distribution, and diabetes with risk of ischemic stroke. The Atherosclerosis Risk in Communities (ARIC) Study Investigators.
      A R Folsom, M L Rasmussen, L E Chambless, G Howard, L S Cooper, M I Schmidt and G Heiss
      Diabetes Care 1999 Jul; 22 (7): 1077-1083. https://doi.org/10.2337/diacare.22.7.1077

  4. Chatterjee, S

    1. 2-year prospective audit of the effect of the introduction of insulin lispro in patients with specific clinical indications.
      S Chatterjee, I W Gallen and L Sandler
      Diabetes Care 1999 Jul; 22 (7): 1226-1227. https://doi.org/10.2337/diacare.22.7.1226

  5. Chen, Y T

    1. Endothelial dysfunction is not reversed by simvastatin treatment in type 2 diabetic patients with hypercholesterolemia.
      W H Sheu, B L Juang, Y T Chen and W J Lee
      Diabetes Care 1999 Jul; 22 (7): 1224-1225. https://doi.org/10.2337/diacare.22.7.1224

  6. Cheng, A Y

    1. Cultural adaptation of the diabetes quality-of-life measure for Chinese patients.
      A Y Cheng, E Y Tsui, A J Hanley and B Zinman
      Diabetes Care 1999 Jul; 22 (7): 1216-1217. https://doi.org/10.2337/diacare.22.7.1216

  7. Chiarelli, F

    1. Increased Na+/Li+ countertransport activity may help to identify type 1 diabetic adolescents and young adults at risk for developing persistent microalbuminuria.
      F Chiarelli, M Catino, S Tumini, M de Martino, A Mezzetti, A Verrotti and M Vanelli
      Diabetes Care 1999 Jul; 22 (7): 1158-1164. https://doi.org/10.2337/diacare.22.7.1158

  8. Cleary, P A

    1. Increased small dense LDL and intermediate-density lipoprotein with albuminuria in type 1 diabetes.
      S D Sibley, J E Hokanson, M W Steffes, J Q Purnell, S M Marcovina, P A Cleary and J D Brunzell
      Diabetes Care 1999 Jul; 22 (7): 1165-1170. https://doi.org/10.2337/diacare.22.7.1165

  9. Collier, G

    1. Is fasting leptin associated with insulin resistance among nondiabetic individuals? The Miami Community Health Study.
      R P Donahue, R J Prineas, R D Donahue, P Zimmet, J A Bean, M De Courten, G Collier, R B Goldberg, J S Skyler and N Schneiderman
      Diabetes Care 1999 Jul; 22 (7): 1092-1096. https://doi.org/10.2337/diacare.22.7.1092

  10. Cooper, L S

    1. Prospective associations of fasting insulin, body fat distribution, and diabetes with risk of ischemic stroke. The Atherosclerosis Risk in Communities (ARIC) Study Investigators.
      A R Folsom, M L Rasmussen, L E Chambless, G Howard, L S Cooper, M I Schmidt and G Heiss
      Diabetes Care 1999 Jul; 22 (7): 1077-1083. https://doi.org/10.2337/diacare.22.7.1077

  11. Cox, D J

    1. Blood glucose awareness training and epinephrine responses to hypoglycemia during intensive treatment in type 1 diabetes.
      B T Kinsley, K Weinger, M Bajaj, C J Levy, D C Simonson, M Quigley, D J Cox and A M Jacobson
      Diabetes Care 1999 Jul; 22 (7): 1022-1028. https://doi.org/10.2337/diacare.22.7.1022

  12. Crowne, E C

    1. Counterregulation during spontaneous nocturnal hypoglycemia in prepubertal children with type 1 diabetes.
      K A Matyka, E C Crowne, P J Havel, I A Macdonald, D Matthews and D B Dunger
      Diabetes Care 1999 Jul; 22 (7): 1144-1150. https://doi.org/10.2337/diacare.22.7.1144

D

  1. Davidson, J

    1. Revised standards for the treatment of type 2 diabetes in Texas.
      J Davidson
      Diabetes Care 1999 Jul; 22 (7): 1219-1220. https://doi.org/10.2337/diacare.22.7.1219

  2. Davignon, D R

    1. A prospective study of risk factors for diabetic foot ulcer. The Seattle Diabetic Foot Study.
      E J Boyko, J H Ahroni, V Stensel, R C Forsberg, D R Davignon and D G Smith
      Diabetes Care 1999 Jul; 22 (7): 1036-1042. https://doi.org/10.2337/diacare.22.7.1036

  3. Deb, P

    1. Work disability and diabetes.
      J A Mayfield, P Deb and L Whitecotton
      Diabetes Care 1999 Jul; 22 (7): 1105-1109. https://doi.org/10.2337/diacare.22.7.1105

  4. De Courten, M

    1. Is fasting leptin associated with insulin resistance among nondiabetic individuals? The Miami Community Health Study.
      R P Donahue, R J Prineas, R D Donahue, P Zimmet, J A Bean, M De Courten, G Collier, R B Goldberg, J S Skyler and N Schneiderman
      Diabetes Care 1999 Jul; 22 (7): 1092-1096. https://doi.org/10.2337/diacare.22.7.1092

  5. Dekker, J M

    1. Leptin and variables of body adiposity, energy balance, and insulin resistance in a population-based study. The Hoorn Study.
      J B Ruige, J M Dekker, W F Blum, C D Stehouwer, G Nijpels, J Mooy, P J Kostense, L M Bouter and R J Heine
      Diabetes Care 1999 Jul; 22 (7): 1097-1104. https://doi.org/10.2337/diacare.22.7.1097

  6. de Martino, M

    1. Increased Na+/Li+ countertransport activity may help to identify type 1 diabetic adolescents and young adults at risk for developing persistent microalbuminuria.
      F Chiarelli, M Catino, S Tumini, M de Martino, A Mezzetti, A Verrotti and M Vanelli
      Diabetes Care 1999 Jul; 22 (7): 1158-1164. https://doi.org/10.2337/diacare.22.7.1158

  7. Donahue, R D

    1. Is fasting leptin associated with insulin resistance among nondiabetic individuals? The Miami Community Health Study.
      R P Donahue, R J Prineas, R D Donahue, P Zimmet, J A Bean, M De Courten, G Collier, R B Goldberg, J S Skyler and N Schneiderman
      Diabetes Care 1999 Jul; 22 (7): 1092-1096. https://doi.org/10.2337/diacare.22.7.1092

  8. Donahue, R P

    1. Is fasting leptin associated with insulin resistance among nondiabetic individuals? The Miami Community Health Study.
      R P Donahue, R J Prineas, R D Donahue, P Zimmet, J A Bean, M De Courten, G Collier, R B Goldberg, J S Skyler and N Schneiderman
      Diabetes Care 1999 Jul; 22 (7): 1092-1096. https://doi.org/10.2337/diacare.22.7.1092

  9. Dunger, D B

    1. Counterregulation during spontaneous nocturnal hypoglycemia in prepubertal children with type 1 diabetes.
      K A Matyka, E C Crowne, P J Havel, I A Macdonald, D Matthews and D B Dunger
      Diabetes Care 1999 Jul; 22 (7): 1144-1150. https://doi.org/10.2337/diacare.22.7.1144

E

  1. Efendic, S

    1. Low birth weight, family history of diabetes, and glucose intolerance in Swedish middle-aged men.
      S Carlsson, P G Persson, M Alvarsson, S Efendic, A Norman, L Svanström, C G Ostenson and V Grill
      Diabetes Care 1999 Jul; 22 (7): 1043-1047. https://doi.org/10.2337/diacare.22.7.1043

  2. Elving, L D

    1. Prevalence of "syndrome X" features in parents of type 1 diabetic patients with or without nephropathy.
      B Verhage, G Vervoort, C Wolkotte, L D Elving, J F Wetzels, H Willems, P Smits, A L Verbeek and J H Berden
      Diabetes Care 1999 Jul; 22 (7): 1048-1052. https://doi.org/10.2337/diacare.22.7.1048

  3. England, B G

    1. Is pregnancy in diabetic women associated with folate deficiency?
      J S Kaplan, S Iqbal, B G England, C M Zawacki and W H Herman
      Diabetes Care 1999 Jul; 22 (7): 1017-1021. https://doi.org/10.2337/diacare.22.7.1017

  4. Erbey, J R

    1. Improved glycemic control reduces the impact of weight gain on cardiovascular risk factors in type 1 diabetes. The Epidemiology of Diabetes Complications Study.
      K V Williams, J R Erbey, D Becker and T J Orchard
      Diabetes Care 1999 Jul; 22 (7): 1084-1091. https://doi.org/10.2337/diacare.22.7.1084

F

  1. Faber, J

    1. Serum levels of advanced glycation end products are associated with left ventricular diastolic function in patients with type 1 diabetes.
      T J Berg, O Snorgaard, J Faber, P A Torjesen, P Hildebrandt, J Mehlsen and K F Hanssen
      Diabetes Care 1999 Jul; 22 (7): 1186-1190. https://doi.org/10.2337/diacare.22.7.1186

  2. Folsom, A R

    1. Prospective associations of fasting insulin, body fat distribution, and diabetes with risk of ischemic stroke. The Atherosclerosis Risk in Communities (ARIC) Study Investigators.
      A R Folsom, M L Rasmussen, L E Chambless, G Howard, L S Cooper, M I Schmidt and G Heiss
      Diabetes Care 1999 Jul; 22 (7): 1077-1083. https://doi.org/10.2337/diacare.22.7.1077

  3. Forsberg, R C

    1. A prospective study of risk factors for diabetic foot ulcer. The Seattle Diabetic Foot Study.
      E J Boyko, J H Ahroni, V Stensel, R C Forsberg, D R Davignon and D G Smith
      Diabetes Care 1999 Jul; 22 (7): 1036-1042. https://doi.org/10.2337/diacare.22.7.1036

  4. Fujiwara, K

    1. Hypersensitivity to regular and intermediate, but not to crystallized, insulin as an aggravation factor for underlying bulimia nervosa in a patient with type 1 diabetes.
      M Itoh, K Uchimura, M Makino, T Kobayashi, H Kakizawa, M Nagata, K Fujiwara, S Kato, Y Itoh and A Nagasaka
      Diabetes Care 1999 Jul; 22 (7): 1221-1224. https://doi.org/10.2337/diacare.22.7.1221

  5. Fukui, M

    1. Clinical features of elderly patients with type 2 diabetes.
      M Fukui, N Nakamura, T Mizutani and M Kondo
      Diabetes Care 1999 Jul; 22 (7): 1225-1226. https://doi.org/10.2337/diacare.22.7.1225

G

  1. Gallen, I W

    1. 2-year prospective audit of the effect of the introduction of insulin lispro in patients with specific clinical indications.
      S Chatterjee, I W Gallen and L Sandler
      Diabetes Care 1999 Jul; 22 (7): 1226-1227. https://doi.org/10.2337/diacare.22.7.1226

  2. Garcia-Ingelmo, T

    1. Early postpartum metabolic assessment in women with prior gestational diabetes.
      F Pallardo, L Herranz, T Garcia-Ingelmo, C Grande, P Martin-Vaquero, M Jañez and A Gonzalez
      Diabetes Care 1999 Jul; 22 (7): 1053-1058. https://doi.org/10.2337/diacare.22.7.1053

  3. Gentile, S

    1. Aminotransferase activity and acarbose treatment in patients with type 2 diabetes.
      S Gentile, S Turco, G Guarino, F C Sasso and R Torella
      Diabetes Care 1999 Jul; 22 (7): 1217-1218. https://doi.org/10.2337/diacare.22.7.1217

  4. Glauber, H S

    1. Type 2 diabetes: incremental medical care costs during the first 8 years after diagnosis.
      J B Brown, G A Nichols, H S Glauber and A W Bakst
      Diabetes Care 1999 Jul; 22 (7): 1116-1124. https://doi.org/10.2337/diacare.22.7.1116

  5. Glick, H A

    1. Determining an episode of care using claims data. Diabetic foot ulcer.
      S S Mehta, S Suzuki, H A Glick and K A Schulman
      Diabetes Care 1999 Jul; 22 (7): 1110-1115. https://doi.org/10.2337/diacare.22.7.1110

  6. Goldberg, R B

    1. Is fasting leptin associated with insulin resistance among nondiabetic individuals? The Miami Community Health Study.
      R P Donahue, R J Prineas, R D Donahue, P Zimmet, J A Bean, M De Courten, G Collier, R B Goldberg, J S Skyler and N Schneiderman
      Diabetes Care 1999 Jul; 22 (7): 1092-1096. https://doi.org/10.2337/diacare.22.7.1092

  7. Gonzalez, A

    1. Early postpartum metabolic assessment in women with prior gestational diabetes.
      F Pallardo, L Herranz, T Garcia-Ingelmo, C Grande, P Martin-Vaquero, M Jañez and A Gonzalez
      Diabetes Care 1999 Jul; 22 (7): 1053-1058. https://doi.org/10.2337/diacare.22.7.1053

  8. Grande, C

    1. Early postpartum metabolic assessment in women with prior gestational diabetes.
      F Pallardo, L Herranz, T Garcia-Ingelmo, C Grande, P Martin-Vaquero, M Jañez and A Gonzalez
      Diabetes Care 1999 Jul; 22 (7): 1053-1058. https://doi.org/10.2337/diacare.22.7.1053

  9. Grill, V

    1. Low birth weight, family history of diabetes, and glucose intolerance in Swedish middle-aged men.
      S Carlsson, P G Persson, M Alvarsson, S Efendic, A Norman, L Svanström, C G Ostenson and V Grill
      Diabetes Care 1999 Jul; 22 (7): 1043-1047. https://doi.org/10.2337/diacare.22.7.1043

  10. Guarino, G

    1. Aminotransferase activity and acarbose treatment in patients with type 2 diabetes.
      S Gentile, S Turco, G Guarino, F C Sasso and R Torella
      Diabetes Care 1999 Jul; 22 (7): 1217-1218. https://doi.org/10.2337/diacare.22.7.1217

H

  1. Hanley, A J

    1. Cultural adaptation of the diabetes quality-of-life measure for Chinese patients.
      A Y Cheng, E Y Tsui, A J Hanley and B Zinman
      Diabetes Care 1999 Jul; 22 (7): 1216-1217. https://doi.org/10.2337/diacare.22.7.1216

  2. Hanssen, K F

    1. Serum levels of advanced glycation end products are associated with left ventricular diastolic function in patients with type 1 diabetes.
      T J Berg, O Snorgaard, J Faber, P A Torjesen, P Hildebrandt, J Mehlsen and K F Hanssen
      Diabetes Care 1999 Jul; 22 (7): 1186-1190. https://doi.org/10.2337/diacare.22.7.1186

  3. Harrower, A

    1. Effect of fiber intake and meal pattern on gastrointestinal symptoms with acarbose.
      A D Harrower, A Harrower and H Jack
      Diabetes Care 1999 Jul; 22 (7): 1227. https://doi.org/10.2337/diacare.22.7.1227b

  4. Harrower, A D

    1. Effect of fiber intake and meal pattern on gastrointestinal symptoms with acarbose.
      A D Harrower, A Harrower and H Jack
      Diabetes Care 1999 Jul; 22 (7): 1227. https://doi.org/10.2337/diacare.22.7.1227b

  5. Havel, P J

    1. Counterregulation during spontaneous nocturnal hypoglycemia in prepubertal children with type 1 diabetes.
      K A Matyka, E C Crowne, P J Havel, I A Macdonald, D Matthews and D B Dunger
      Diabetes Care 1999 Jul; 22 (7): 1144-1150. https://doi.org/10.2337/diacare.22.7.1144

  6. Hayakawa, M

    1. Increased urinary transferrin excretion predicts microalbuminuria in patients with type 2 diabetes.
      T Kazumi, T Hozumi, Y Ishida, Y Ikeda, K Kishi, M Hayakawa and G Yoshino
      Diabetes Care 1999 Jul; 22 (7): 1176-1180. https://doi.org/10.2337/diacare.22.7.1176

  7. Hayakawa, T

    1. Low-density lipoprotein particle size as an independent predictor of glycated low-density lipoprotein level.
      H Matsui, K Okumura, Y Toki and T Hayakawa
      Diabetes Care 1999 Jul; 22 (7): 1220-1221. https://doi.org/10.2337/diacare.22.7.1220a

  8. Heine, R J

    1. Leptin and variables of body adiposity, energy balance, and insulin resistance in a population-based study. The Hoorn Study.
      J B Ruige, J M Dekker, W F Blum, C D Stehouwer, G Nijpels, J Mooy, P J Kostense, L M Bouter and R J Heine
      Diabetes Care 1999 Jul; 22 (7): 1097-1104. https://doi.org/10.2337/diacare.22.7.1097

  9. Heinze, E

    1. Circadian blood pressure during the early course of type 1 diabetes. Analysis of 1,011 ambulatory blood pressure recordings in 354 adolescents and young adults.
      R W Holl, M Pavlovic, E Heinze and A Thon
      Diabetes Care 1999 Jul; 22 (7): 1151-1157. https://doi.org/10.2337/diacare.22.7.1151

  10. Heiss, G

    1. Prospective associations of fasting insulin, body fat distribution, and diabetes with risk of ischemic stroke. The Atherosclerosis Risk in Communities (ARIC) Study Investigators.
      A R Folsom, M L Rasmussen, L E Chambless, G Howard, L S Cooper, M I Schmidt and G Heiss
      Diabetes Care 1999 Jul; 22 (7): 1077-1083. https://doi.org/10.2337/diacare.22.7.1077

  11. Herman, W H

    1. Is pregnancy in diabetic women associated with folate deficiency?
      J S Kaplan, S Iqbal, B G England, C M Zawacki and W H Herman
      Diabetes Care 1999 Jul; 22 (7): 1017-1021. https://doi.org/10.2337/diacare.22.7.1017

  12. Herranz, L

    1. Early postpartum metabolic assessment in women with prior gestational diabetes.
      F Pallardo, L Herranz, T Garcia-Ingelmo, C Grande, P Martin-Vaquero, M Jañez and A Gonzalez
      Diabetes Care 1999 Jul; 22 (7): 1053-1058. https://doi.org/10.2337/diacare.22.7.1053

  13. Hildebrandt, P

    1. Serum levels of advanced glycation end products are associated with left ventricular diastolic function in patients with type 1 diabetes.
      T J Berg, O Snorgaard, J Faber, P A Torjesen, P Hildebrandt, J Mehlsen and K F Hanssen
      Diabetes Care 1999 Jul; 22 (7): 1186-1190. https://doi.org/10.2337/diacare.22.7.1186

  14. Hirao, K

    1. Insulin resistance and classic risk factors in type 2 diabetic patients with different subtypes of ischemic stroke.
      K Matsumoto, S Miyake, M Yano, Y Ueki, A Miyazaki, K Hirao and Y Tominaga
      Diabetes Care 1999 Jul; 22 (7): 1191-1195. https://doi.org/10.2337/diacare.22.7.1191

  15. Hokanson, J E

    1. Increased small dense LDL and intermediate-density lipoprotein with albuminuria in type 1 diabetes.
      S D Sibley, J E Hokanson, M W Steffes, J Q Purnell, S M Marcovina, P A Cleary and J D Brunzell
      Diabetes Care 1999 Jul; 22 (7): 1165-1170. https://doi.org/10.2337/diacare.22.7.1165

  16. Holl, R W

    1. Circadian blood pressure during the early course of type 1 diabetes. Analysis of 1,011 ambulatory blood pressure recordings in 354 adolescents and young adults.
      R W Holl, M Pavlovic, E Heinze and A Thon
      Diabetes Care 1999 Jul; 22 (7): 1151-1157. https://doi.org/10.2337/diacare.22.7.1151

  17. Holst, J J

    1. Continuous subcutaneous infusion of glucagon-like peptide 1 lowers plasma glucose and reduces appetite in type 2 diabetic patients.
      M B Toft-Nielsen, S Madsbad and J J Holst
      Diabetes Care 1999 Jul; 22 (7): 1137-1143. https://doi.org/10.2337/diacare.22.7.1137

  18. Howard, G

    1. Prospective associations of fasting insulin, body fat distribution, and diabetes with risk of ischemic stroke. The Atherosclerosis Risk in Communities (ARIC) Study Investigators.
      A R Folsom, M L Rasmussen, L E Chambless, G Howard, L S Cooper, M I Schmidt and G Heiss
      Diabetes Care 1999 Jul; 22 (7): 1077-1083. https://doi.org/10.2337/diacare.22.7.1077

  19. Hozumi, T

    1. Increased urinary transferrin excretion predicts microalbuminuria in patients with type 2 diabetes.
      T Kazumi, T Hozumi, Y Ishida, Y Ikeda, K Kishi, M Hayakawa and G Yoshino
      Diabetes Care 1999 Jul; 22 (7): 1176-1180. https://doi.org/10.2337/diacare.22.7.1176

  20. Hsiao, P J

    1. Increased urinary atrial natriuretic peptide-like immunoreactivity excretion but decreased plasma atrial natriuretic peptide concentration in patients with hyperosmolar-hyperglycemic nonketotic syndrome.
      S J Shin, Y J Lee, P J Hsiao and J H Tsai
      Diabetes Care 1999 Jul; 22 (7): 1181-1185. https://doi.org/10.2337/diacare.22.7.1181

I

  1. Ikeda, Y

    1. Increased urinary transferrin excretion predicts microalbuminuria in patients with type 2 diabetes.
      T Kazumi, T Hozumi, Y Ishida, Y Ikeda, K Kishi, M Hayakawa and G Yoshino
      Diabetes Care 1999 Jul; 22 (7): 1176-1180. https://doi.org/10.2337/diacare.22.7.1176

  2. Impivaara, O

    1. Bone mineral density in patients with type 1 and type 2 diabetes.
      J T Tuominen, O Impivaara, P Puukka and T Rönnemaa
      Diabetes Care 1999 Jul; 22 (7): 1196-1200. https://doi.org/10.2337/diacare.22.7.1196

  3. Iqbal, S

    1. Is pregnancy in diabetic women associated with folate deficiency?
      J S Kaplan, S Iqbal, B G England, C M Zawacki and W H Herman
      Diabetes Care 1999 Jul; 22 (7): 1017-1021. https://doi.org/10.2337/diacare.22.7.1017

  4. Isermann, B

    1. alpha-Tocopherol induces leptin expression in healthy individuals and in vitro.
      B Isermann, A Bierhaus, H Tritschler, R Ziegler and P P Nawroth
      Diabetes Care 1999 Jul; 22 (7): 1227-1228. https://doi.org/10.2337/diacare.22.7.1227a

  5. Ishibashi, H

    1. Depressive symptoms and occurrence of type 2 diabetes among Japanese men.
      N Kawakami, N Takatsuka, H Shimizu and H Ishibashi
      Diabetes Care 1999 Jul; 22 (7): 1071-1076. https://doi.org/10.2337/diacare.22.7.1071

  6. Ishida, Y

    1. Increased urinary transferrin excretion predicts microalbuminuria in patients with type 2 diabetes.
      T Kazumi, T Hozumi, Y Ishida, Y Ikeda, K Kishi, M Hayakawa and G Yoshino
      Diabetes Care 1999 Jul; 22 (7): 1176-1180. https://doi.org/10.2337/diacare.22.7.1176

  7. Itoh, M

    1. Hypersensitivity to regular and intermediate, but not to crystallized, insulin as an aggravation factor for underlying bulimia nervosa in a patient with type 1 diabetes.
      M Itoh, K Uchimura, M Makino, T Kobayashi, H Kakizawa, M Nagata, K Fujiwara, S Kato, Y Itoh and A Nagasaka
      Diabetes Care 1999 Jul; 22 (7): 1221-1224. https://doi.org/10.2337/diacare.22.7.1221

  8. Itoh, Y

    1. Hypersensitivity to regular and intermediate, but not to crystallized, insulin as an aggravation factor for underlying bulimia nervosa in a patient with type 1 diabetes.
      M Itoh, K Uchimura, M Makino, T Kobayashi, H Kakizawa, M Nagata, K Fujiwara, S Kato, Y Itoh and A Nagasaka
      Diabetes Care 1999 Jul; 22 (7): 1221-1224. https://doi.org/10.2337/diacare.22.7.1221

J

  1. Jack, H

    1. Effect of fiber intake and meal pattern on gastrointestinal symptoms with acarbose.
      A D Harrower, A Harrower and H Jack
      Diabetes Care 1999 Jul; 22 (7): 1227. https://doi.org/10.2337/diacare.22.7.1227b

  2. Jackson, R

    1. Effect of hyperketonemia on plasma lipid peroxidation levels in diabetic patients.
      S K Jain, R McVie, R Jackson, S N Levine and G Lim
      Diabetes Care 1999 Jul; 22 (7): 1171-1175. https://doi.org/10.2337/diacare.22.7.1171

  3. Jacobson, A M

    1. Blood glucose awareness training and epinephrine responses to hypoglycemia during intensive treatment in type 1 diabetes.
      B T Kinsley, K Weinger, M Bajaj, C J Levy, D C Simonson, M Quigley, D J Cox and A M Jacobson
      Diabetes Care 1999 Jul; 22 (7): 1022-1028. https://doi.org/10.2337/diacare.22.7.1022

  4. Jain, S K

    1. Effect of hyperketonemia on plasma lipid peroxidation levels in diabetic patients.
      S K Jain, R McVie, R Jackson, S N Levine and G Lim
      Diabetes Care 1999 Jul; 22 (7): 1171-1175. https://doi.org/10.2337/diacare.22.7.1171

  5. Jañez, M

    1. Early postpartum metabolic assessment in women with prior gestational diabetes.
      F Pallardo, L Herranz, T Garcia-Ingelmo, C Grande, P Martin-Vaquero, M Jañez and A Gonzalez
      Diabetes Care 1999 Jul; 22 (7): 1053-1058. https://doi.org/10.2337/diacare.22.7.1053

  6. Juang, B L

    1. Endothelial dysfunction is not reversed by simvastatin treatment in type 2 diabetic patients with hypercholesterolemia.
      W H Sheu, B L Juang, Y T Chen and W J Lee
      Diabetes Care 1999 Jul; 22 (7): 1224-1225. https://doi.org/10.2337/diacare.22.7.1224

K

  1. Kakizawa, H

    1. Hypersensitivity to regular and intermediate, but not to crystallized, insulin as an aggravation factor for underlying bulimia nervosa in a patient with type 1 diabetes.
      M Itoh, K Uchimura, M Makino, T Kobayashi, H Kakizawa, M Nagata, K Fujiwara, S Kato, Y Itoh and A Nagasaka
      Diabetes Care 1999 Jul; 22 (7): 1221-1224. https://doi.org/10.2337/diacare.22.7.1221

  2. Kaplan, J S

    1. Is pregnancy in diabetic women associated with folate deficiency?
      J S Kaplan, S Iqbal, B G England, C M Zawacki and W H Herman
      Diabetes Care 1999 Jul; 22 (7): 1017-1021. https://doi.org/10.2337/diacare.22.7.1017

  3. Karvonen, M

    1. The onset age of type 1 diabetes in Finnish children has become younger. The Finnish Childhood Diabetes Registry Group.
      M Karvonen, J Pitkäniemi and J Tuomilehto
      Diabetes Care 1999 Jul; 22 (7): 1066-1070. https://doi.org/10.2337/diacare.22.7.1066

  4. Kato, S

    1. Hypersensitivity to regular and intermediate, but not to crystallized, insulin as an aggravation factor for underlying bulimia nervosa in a patient with type 1 diabetes.
      M Itoh, K Uchimura, M Makino, T Kobayashi, H Kakizawa, M Nagata, K Fujiwara, S Kato, Y Itoh and A Nagasaka
      Diabetes Care 1999 Jul; 22 (7): 1221-1224. https://doi.org/10.2337/diacare.22.7.1221

  5. Kawakami, N

    1. Depressive symptoms and occurrence of type 2 diabetes among Japanese men.
      N Kawakami, N Takatsuka, H Shimizu and H Ishibashi
      Diabetes Care 1999 Jul; 22 (7): 1071-1076. https://doi.org/10.2337/diacare.22.7.1071

  6. Kazumi, T

    1. Increased urinary transferrin excretion predicts microalbuminuria in patients with type 2 diabetes.
      T Kazumi, T Hozumi, Y Ishida, Y Ikeda, K Kishi, M Hayakawa and G Yoshino
      Diabetes Care 1999 Jul; 22 (7): 1176-1180. https://doi.org/10.2337/diacare.22.7.1176

  7. Kinsley, B T

    1. Blood glucose awareness training and epinephrine responses to hypoglycemia during intensive treatment in type 1 diabetes.
      B T Kinsley, K Weinger, M Bajaj, C J Levy, D C Simonson, M Quigley, D J Cox and A M Jacobson
      Diabetes Care 1999 Jul; 22 (7): 1022-1028. https://doi.org/10.2337/diacare.22.7.1022

  8. Kishi, K

    1. Increased urinary transferrin excretion predicts microalbuminuria in patients with type 2 diabetes.
      T Kazumi, T Hozumi, Y Ishida, Y Ikeda, K Kishi, M Hayakawa and G Yoshino
      Diabetes Care 1999 Jul; 22 (7): 1176-1180. https://doi.org/10.2337/diacare.22.7.1176

  9. Knights, S

    1. Birth weight of women with gestational diabetes.
      R G Moses, J Moses and S Knights
      Diabetes Care 1999 Jul; 22 (7): 1059-1062. https://doi.org/10.2337/diacare.22.7.1059

  10. Kobayashi, T

    1. Hypersensitivity to regular and intermediate, but not to crystallized, insulin as an aggravation factor for underlying bulimia nervosa in a patient with type 1 diabetes.
      M Itoh, K Uchimura, M Makino, T Kobayashi, H Kakizawa, M Nagata, K Fujiwara, S Kato, Y Itoh and A Nagasaka
      Diabetes Care 1999 Jul; 22 (7): 1221-1224. https://doi.org/10.2337/diacare.22.7.1221

  11. Kondo, M

    1. Clinical features of elderly patients with type 2 diabetes.
      M Fukui, N Nakamura, T Mizutani and M Kondo
      Diabetes Care 1999 Jul; 22 (7): 1225-1226. https://doi.org/10.2337/diacare.22.7.1225

  12. Kostense, P J

    1. Leptin and variables of body adiposity, energy balance, and insulin resistance in a population-based study. The Hoorn Study.
      J B Ruige, J M Dekker, W F Blum, C D Stehouwer, G Nijpels, J Mooy, P J Kostense, L M Bouter and R J Heine
      Diabetes Care 1999 Jul; 22 (7): 1097-1104. https://doi.org/10.2337/diacare.22.7.1097

L

  1. Lee, W J

    1. Endothelial dysfunction is not reversed by simvastatin treatment in type 2 diabetic patients with hypercholesterolemia.
      W H Sheu, B L Juang, Y T Chen and W J Lee
      Diabetes Care 1999 Jul; 22 (7): 1224-1225. https://doi.org/10.2337/diacare.22.7.1224

  2. Lee, Y J

    1. Increased urinary atrial natriuretic peptide-like immunoreactivity excretion but decreased plasma atrial natriuretic peptide concentration in patients with hyperosmolar-hyperglycemic nonketotic syndrome.
      S J Shin, Y J Lee, P J Hsiao and J H Tsai
      Diabetes Care 1999 Jul; 22 (7): 1181-1185. https://doi.org/10.2337/diacare.22.7.1181

  3. Levine, S N

    1. Effect of hyperketonemia on plasma lipid peroxidation levels in diabetic patients.
      S K Jain, R McVie, R Jackson, S N Levine and G Lim
      Diabetes Care 1999 Jul; 22 (7): 1171-1175. https://doi.org/10.2337/diacare.22.7.1171

  4. Levy, C J

    1. Blood glucose awareness training and epinephrine responses to hypoglycemia during intensive treatment in type 1 diabetes.
      B T Kinsley, K Weinger, M Bajaj, C J Levy, D C Simonson, M Quigley, D J Cox and A M Jacobson
      Diabetes Care 1999 Jul; 22 (7): 1022-1028. https://doi.org/10.2337/diacare.22.7.1022

  5. Lim, G

    1. Effect of hyperketonemia on plasma lipid peroxidation levels in diabetic patients.
      S K Jain, R McVie, R Jackson, S N Levine and G Lim
      Diabetes Care 1999 Jul; 22 (7): 1171-1175. https://doi.org/10.2337/diacare.22.7.1171

M

  1. Macdonald, I A

    1. Counterregulation during spontaneous nocturnal hypoglycemia in prepubertal children with type 1 diabetes.
      K A Matyka, E C Crowne, P J Havel, I A Macdonald, D Matthews and D B Dunger
      Diabetes Care 1999 Jul; 22 (7): 1144-1150. https://doi.org/10.2337/diacare.22.7.1144

  2. Madsbad, S

    1. Continuous subcutaneous infusion of glucagon-like peptide 1 lowers plasma glucose and reduces appetite in type 2 diabetic patients.
      M B Toft-Nielsen, S Madsbad and J J Holst
      Diabetes Care 1999 Jul; 22 (7): 1137-1143. https://doi.org/10.2337/diacare.22.7.1137

  3. Makino, M

    1. Hypersensitivity to regular and intermediate, but not to crystallized, insulin as an aggravation factor for underlying bulimia nervosa in a patient with type 1 diabetes.
      M Itoh, K Uchimura, M Makino, T Kobayashi, H Kakizawa, M Nagata, K Fujiwara, S Kato, Y Itoh and A Nagasaka
      Diabetes Care 1999 Jul; 22 (7): 1221-1224. https://doi.org/10.2337/diacare.22.7.1221

  4. Marcovina, S M

    1. Increased small dense LDL and intermediate-density lipoprotein with albuminuria in type 1 diabetes.
      S D Sibley, J E Hokanson, M W Steffes, J Q Purnell, S M Marcovina, P A Cleary and J D Brunzell
      Diabetes Care 1999 Jul; 22 (7): 1165-1170. https://doi.org/10.2337/diacare.22.7.1165

  5. Martin-Vaquero, P

    1. Early postpartum metabolic assessment in women with prior gestational diabetes.
      F Pallardo, L Herranz, T Garcia-Ingelmo, C Grande, P Martin-Vaquero, M Jañez and A Gonzalez
      Diabetes Care 1999 Jul; 22 (7): 1053-1058. https://doi.org/10.2337/diacare.22.7.1053

  6. Mason, P E

    1. Calcium antagonists and cardiovascular risk in diabetes. A review of the evidence.
      R P Mason and P E Mason
      Diabetes Care 1999 Jul; 22 (7): 1206-1208. https://doi.org/10.2337/diacare.22.7.1206

  7. Mason, R P

    1. Calcium antagonists and cardiovascular risk in diabetes. A review of the evidence.
      R P Mason and P E Mason
      Diabetes Care 1999 Jul; 22 (7): 1206-1208. https://doi.org/10.2337/diacare.22.7.1206

  8. Matsui, H

    1. Low-density lipoprotein particle size as an independent predictor of glycated low-density lipoprotein level.
      H Matsui, K Okumura, Y Toki and T Hayakawa
      Diabetes Care 1999 Jul; 22 (7): 1220-1221. https://doi.org/10.2337/diacare.22.7.1220a

  9. Matsumoto, K

    1. Insulin resistance and classic risk factors in type 2 diabetic patients with different subtypes of ischemic stroke.
      K Matsumoto, S Miyake, M Yano, Y Ueki, A Miyazaki, K Hirao and Y Tominaga
      Diabetes Care 1999 Jul; 22 (7): 1191-1195. https://doi.org/10.2337/diacare.22.7.1191

  10. Matthews, D

    1. Counterregulation during spontaneous nocturnal hypoglycemia in prepubertal children with type 1 diabetes.
      K A Matyka, E C Crowne, P J Havel, I A Macdonald, D Matthews and D B Dunger
      Diabetes Care 1999 Jul; 22 (7): 1144-1150. https://doi.org/10.2337/diacare.22.7.1144

  11. Matyka, K A

    1. Counterregulation during spontaneous nocturnal hypoglycemia in prepubertal children with type 1 diabetes.
      K A Matyka, E C Crowne, P J Havel, I A Macdonald, D Matthews and D B Dunger
      Diabetes Care 1999 Jul; 22 (7): 1144-1150. https://doi.org/10.2337/diacare.22.7.1144

  12. Mayfield, J A

    1. Work disability and diabetes.
      J A Mayfield, P Deb and L Whitecotton
      Diabetes Care 1999 Jul; 22 (7): 1105-1109. https://doi.org/10.2337/diacare.22.7.1105

  13. McVie, R

    1. Effect of hyperketonemia on plasma lipid peroxidation levels in diabetic patients.
      S K Jain, R McVie, R Jackson, S N Levine and G Lim
      Diabetes Care 1999 Jul; 22 (7): 1171-1175. https://doi.org/10.2337/diacare.22.7.1171

  14. Mehlsen, J

    1. Serum levels of advanced glycation end products are associated with left ventricular diastolic function in patients with type 1 diabetes.
      T J Berg, O Snorgaard, J Faber, P A Torjesen, P Hildebrandt, J Mehlsen and K F Hanssen
      Diabetes Care 1999 Jul; 22 (7): 1186-1190. https://doi.org/10.2337/diacare.22.7.1186

  15. Mehta, S S

    1. Determining an episode of care using claims data. Diabetic foot ulcer.
      S S Mehta, S Suzuki, H A Glick and K A Schulman
      Diabetes Care 1999 Jul; 22 (7): 1110-1115. https://doi.org/10.2337/diacare.22.7.1110

  16. Mezzetti, A

    1. Increased Na+/Li+ countertransport activity may help to identify type 1 diabetic adolescents and young adults at risk for developing persistent microalbuminuria.
      F Chiarelli, M Catino, S Tumini, M de Martino, A Mezzetti, A Verrotti and M Vanelli
      Diabetes Care 1999 Jul; 22 (7): 1158-1164. https://doi.org/10.2337/diacare.22.7.1158

  17. Miyake, S

    1. Insulin resistance and classic risk factors in type 2 diabetic patients with different subtypes of ischemic stroke.
      K Matsumoto, S Miyake, M Yano, Y Ueki, A Miyazaki, K Hirao and Y Tominaga
      Diabetes Care 1999 Jul; 22 (7): 1191-1195. https://doi.org/10.2337/diacare.22.7.1191

  18. Miyazaki, A

    1. Insulin resistance and classic risk factors in type 2 diabetic patients with different subtypes of ischemic stroke.
      K Matsumoto, S Miyake, M Yano, Y Ueki, A Miyazaki, K Hirao and Y Tominaga
      Diabetes Care 1999 Jul; 22 (7): 1191-1195. https://doi.org/10.2337/diacare.22.7.1191

  19. Mizutani, T

    1. Clinical features of elderly patients with type 2 diabetes.
      M Fukui, N Nakamura, T Mizutani and M Kondo
      Diabetes Care 1999 Jul; 22 (7): 1225-1226. https://doi.org/10.2337/diacare.22.7.1225

  20. Mooy, J

    1. Leptin and variables of body adiposity, energy balance, and insulin resistance in a population-based study. The Hoorn Study.
      J B Ruige, J M Dekker, W F Blum, C D Stehouwer, G Nijpels, J Mooy, P J Kostense, L M Bouter and R J Heine
      Diabetes Care 1999 Jul; 22 (7): 1097-1104. https://doi.org/10.2337/diacare.22.7.1097

  21. Moses, J

    1. Birth weight of women with gestational diabetes.
      R G Moses, J Moses and S Knights
      Diabetes Care 1999 Jul; 22 (7): 1059-1062. https://doi.org/10.2337/diacare.22.7.1059

  22. Moses, R G

    1. Birth weight of women with gestational diabetes.
      R G Moses, J Moses and S Knights
      Diabetes Care 1999 Jul; 22 (7): 1059-1062. https://doi.org/10.2337/diacare.22.7.1059

N

  1. Nagasaka, A

    1. Hypersensitivity to regular and intermediate, but not to crystallized, insulin as an aggravation factor for underlying bulimia nervosa in a patient with type 1 diabetes.
      M Itoh, K Uchimura, M Makino, T Kobayashi, H Kakizawa, M Nagata, K Fujiwara, S Kato, Y Itoh and A Nagasaka
      Diabetes Care 1999 Jul; 22 (7): 1221-1224. https://doi.org/10.2337/diacare.22.7.1221

  2. Nagata, M

    1. Hypersensitivity to regular and intermediate, but not to crystallized, insulin as an aggravation factor for underlying bulimia nervosa in a patient with type 1 diabetes.
      M Itoh, K Uchimura, M Makino, T Kobayashi, H Kakizawa, M Nagata, K Fujiwara, S Kato, Y Itoh and A Nagasaka
      Diabetes Care 1999 Jul; 22 (7): 1221-1224. https://doi.org/10.2337/diacare.22.7.1221

  3. Nakamura, N

    1. Clinical features of elderly patients with type 2 diabetes.
      M Fukui, N Nakamura, T Mizutani and M Kondo
      Diabetes Care 1999 Jul; 22 (7): 1225-1226. https://doi.org/10.2337/diacare.22.7.1225

  4. Nawroth, P P

    1. alpha-Tocopherol induces leptin expression in healthy individuals and in vitro.
      B Isermann, A Bierhaus, H Tritschler, R Ziegler and P P Nawroth
      Diabetes Care 1999 Jul; 22 (7): 1227-1228. https://doi.org/10.2337/diacare.22.7.1227a

  5. Nichols, G A

    1. Type 2 diabetes: incremental medical care costs during the first 8 years after diagnosis.
      J B Brown, G A Nichols, H S Glauber and A W Bakst
      Diabetes Care 1999 Jul; 22 (7): 1116-1124. https://doi.org/10.2337/diacare.22.7.1116

  6. Nijpels, G

    1. Leptin and variables of body adiposity, energy balance, and insulin resistance in a population-based study. The Hoorn Study.
      J B Ruige, J M Dekker, W F Blum, C D Stehouwer, G Nijpels, J Mooy, P J Kostense, L M Bouter and R J Heine
      Diabetes Care 1999 Jul; 22 (7): 1097-1104. https://doi.org/10.2337/diacare.22.7.1097

  7. Norman, A

    1. Low birth weight, family history of diabetes, and glucose intolerance in Swedish middle-aged men.
      S Carlsson, P G Persson, M Alvarsson, S Efendic, A Norman, L Svanström, C G Ostenson and V Grill
      Diabetes Care 1999 Jul; 22 (7): 1043-1047. https://doi.org/10.2337/diacare.22.7.1043

O

  1. Okumura, K

    1. Low-density lipoprotein particle size as an independent predictor of glycated low-density lipoprotein level.
      H Matsui, K Okumura, Y Toki and T Hayakawa
      Diabetes Care 1999 Jul; 22 (7): 1220-1221. https://doi.org/10.2337/diacare.22.7.1220a

  2. Orchard, T J

    1. Improved glycemic control reduces the impact of weight gain on cardiovascular risk factors in type 1 diabetes. The Epidemiology of Diabetes Complications Study.
      K V Williams, J R Erbey, D Becker and T J Orchard
      Diabetes Care 1999 Jul; 22 (7): 1084-1091. https://doi.org/10.2337/diacare.22.7.1084
    2. Glycemic control and CAD risk: a heretical thought.
      T J Orchard
      Diabetes Care 1999 Jul; 22 (7): 1220. https://doi.org/10.2337/diacare.22.7.1220b

  3. Ostenson, C G

    1. Low birth weight, family history of diabetes, and glucose intolerance in Swedish middle-aged men.
      S Carlsson, P G Persson, M Alvarsson, S Efendic, A Norman, L Svanström, C G Ostenson and V Grill
      Diabetes Care 1999 Jul; 22 (7): 1043-1047. https://doi.org/10.2337/diacare.22.7.1043

P

  1. Pallardo, F

    1. Early postpartum metabolic assessment in women with prior gestational diabetes.
      F Pallardo, L Herranz, T Garcia-Ingelmo, C Grande, P Martin-Vaquero, M Jañez and A Gonzalez
      Diabetes Care 1999 Jul; 22 (7): 1053-1058. https://doi.org/10.2337/diacare.22.7.1053

  2. Pavlovic, M

    1. Circadian blood pressure during the early course of type 1 diabetes. Analysis of 1,011 ambulatory blood pressure recordings in 354 adolescents and young adults.
      R W Holl, M Pavlovic, E Heinze and A Thon
      Diabetes Care 1999 Jul; 22 (7): 1151-1157. https://doi.org/10.2337/diacare.22.7.1151

  3. Persson, P G

    1. Low birth weight, family history of diabetes, and glucose intolerance in Swedish middle-aged men.
      S Carlsson, P G Persson, M Alvarsson, S Efendic, A Norman, L Svanström, C G Ostenson and V Grill
      Diabetes Care 1999 Jul; 22 (7): 1043-1047. https://doi.org/10.2337/diacare.22.7.1043

  4. Pitkäniemi, J

    1. The onset age of type 1 diabetes in Finnish children has become younger. The Finnish Childhood Diabetes Registry Group.
      M Karvonen, J Pitkäniemi and J Tuomilehto
      Diabetes Care 1999 Jul; 22 (7): 1066-1070. https://doi.org/10.2337/diacare.22.7.1066

  5. Prineas, R J

    1. Is fasting leptin associated with insulin resistance among nondiabetic individuals? The Miami Community Health Study.
      R P Donahue, R J Prineas, R D Donahue, P Zimmet, J A Bean, M De Courten, G Collier, R B Goldberg, J S Skyler and N Schneiderman
      Diabetes Care 1999 Jul; 22 (7): 1092-1096. https://doi.org/10.2337/diacare.22.7.1092

  6. Purnell, J Q

    1. Increased small dense LDL and intermediate-density lipoprotein with albuminuria in type 1 diabetes.
      S D Sibley, J E Hokanson, M W Steffes, J Q Purnell, S M Marcovina, P A Cleary and J D Brunzell
      Diabetes Care 1999 Jul; 22 (7): 1165-1170. https://doi.org/10.2337/diacare.22.7.1165

  7. Puukka, P

    1. Bone mineral density in patients with type 1 and type 2 diabetes.
      J T Tuominen, O Impivaara, P Puukka and T Rönnemaa
      Diabetes Care 1999 Jul; 22 (7): 1196-1200. https://doi.org/10.2337/diacare.22.7.1196

Q

  1. Quigley, M

    1. Blood glucose awareness training and epinephrine responses to hypoglycemia during intensive treatment in type 1 diabetes.
      B T Kinsley, K Weinger, M Bajaj, C J Levy, D C Simonson, M Quigley, D J Cox and A M Jacobson
      Diabetes Care 1999 Jul; 22 (7): 1022-1028. https://doi.org/10.2337/diacare.22.7.1022

R

  1. Rasmussen, M L

    1. Prospective associations of fasting insulin, body fat distribution, and diabetes with risk of ischemic stroke. The Atherosclerosis Risk in Communities (ARIC) Study Investigators.
      A R Folsom, M L Rasmussen, L E Chambless, G Howard, L S Cooper, M I Schmidt and G Heiss
      Diabetes Care 1999 Jul; 22 (7): 1077-1083. https://doi.org/10.2337/diacare.22.7.1077

  2. Rönnemaa, T

    1. Bone mineral density in patients with type 1 and type 2 diabetes.
      J T Tuominen, O Impivaara, P Puukka and T Rönnemaa
      Diabetes Care 1999 Jul; 22 (7): 1196-1200. https://doi.org/10.2337/diacare.22.7.1196

  3. Ruige, J B

    1. Leptin and variables of body adiposity, energy balance, and insulin resistance in a population-based study. The Hoorn Study.
      J B Ruige, J M Dekker, W F Blum, C D Stehouwer, G Nijpels, J Mooy, P J Kostense, L M Bouter and R J Heine
      Diabetes Care 1999 Jul; 22 (7): 1097-1104. https://doi.org/10.2337/diacare.22.7.1097

S

  1. Sandler, L

    1. 2-year prospective audit of the effect of the introduction of insulin lispro in patients with specific clinical indications.
      S Chatterjee, I W Gallen and L Sandler
      Diabetes Care 1999 Jul; 22 (7): 1226-1227. https://doi.org/10.2337/diacare.22.7.1226

  2. Sasso, F C

    1. Aminotransferase activity and acarbose treatment in patients with type 2 diabetes.
      S Gentile, S Turco, G Guarino, F C Sasso and R Torella
      Diabetes Care 1999 Jul; 22 (7): 1217-1218. https://doi.org/10.2337/diacare.22.7.1217

  3. Schmidt, M I

    1. Prospective associations of fasting insulin, body fat distribution, and diabetes with risk of ischemic stroke. The Atherosclerosis Risk in Communities (ARIC) Study Investigators.
      A R Folsom, M L Rasmussen, L E Chambless, G Howard, L S Cooper, M I Schmidt and G Heiss
      Diabetes Care 1999 Jul; 22 (7): 1077-1083. https://doi.org/10.2337/diacare.22.7.1077

  4. Schneiderman, N

    1. Is fasting leptin associated with insulin resistance among nondiabetic individuals? The Miami Community Health Study.
      R P Donahue, R J Prineas, R D Donahue, P Zimmet, J A Bean, M De Courten, G Collier, R B Goldberg, J S Skyler and N Schneiderman
      Diabetes Care 1999 Jul; 22 (7): 1092-1096. https://doi.org/10.2337/diacare.22.7.1092

  5. Schulman, K A

    1. Determining an episode of care using claims data. Diabetic foot ulcer.
      S S Mehta, S Suzuki, H A Glick and K A Schulman
      Diabetes Care 1999 Jul; 22 (7): 1110-1115. https://doi.org/10.2337/diacare.22.7.1110

  6. Schwartz, R

    1. What is the significance of macrosomia?
      R Schwartz and K A Teramo
      Diabetes Care 1999 Jul; 22 (7): 1201-1205. https://doi.org/10.2337/diacare.22.7.1201

  7. Sheu, W H

    1. Endothelial dysfunction is not reversed by simvastatin treatment in type 2 diabetic patients with hypercholesterolemia.
      W H Sheu, B L Juang, Y T Chen and W J Lee
      Diabetes Care 1999 Jul; 22 (7): 1224-1225. https://doi.org/10.2337/diacare.22.7.1224

  8. Shimizu, H

    1. Depressive symptoms and occurrence of type 2 diabetes among Japanese men.
      N Kawakami, N Takatsuka, H Shimizu and H Ishibashi
      Diabetes Care 1999 Jul; 22 (7): 1071-1076. https://doi.org/10.2337/diacare.22.7.1071

  9. Shin, S J

    1. Increased urinary atrial natriuretic peptide-like immunoreactivity excretion but decreased plasma atrial natriuretic peptide concentration in patients with hyperosmolar-hyperglycemic nonketotic syndrome.
      S J Shin, Y J Lee, P J Hsiao and J H Tsai
      Diabetes Care 1999 Jul; 22 (7): 1181-1185. https://doi.org/10.2337/diacare.22.7.1181

  10. Sibley, S D

    1. Increased small dense LDL and intermediate-density lipoprotein with albuminuria in type 1 diabetes.
      S D Sibley, J E Hokanson, M W Steffes, J Q Purnell, S M Marcovina, P A Cleary and J D Brunzell
      Diabetes Care 1999 Jul; 22 (7): 1165-1170. https://doi.org/10.2337/diacare.22.7.1165

  11. Simonson, D C

    1. Blood glucose awareness training and epinephrine responses to hypoglycemia during intensive treatment in type 1 diabetes.
      B T Kinsley, K Weinger, M Bajaj, C J Levy, D C Simonson, M Quigley, D J Cox and A M Jacobson
      Diabetes Care 1999 Jul; 22 (7): 1022-1028. https://doi.org/10.2337/diacare.22.7.1022

  12. Skyler, J S

    1. Is fasting leptin associated with insulin resistance among nondiabetic individuals? The Miami Community Health Study.
      R P Donahue, R J Prineas, R D Donahue, P Zimmet, J A Bean, M De Courten, G Collier, R B Goldberg, J S Skyler and N Schneiderman
      Diabetes Care 1999 Jul; 22 (7): 1092-1096. https://doi.org/10.2337/diacare.22.7.1092

  13. Smith, D G

    1. Lower-extremity amputation in diabetes. The independent effects of peripheral vascular disease, sensory neuropathy, and foot ulcers.
      A I Adler, E J Boyko, J H Ahroni and D G Smith
      Diabetes Care 1999 Jul; 22 (7): 1029-1035. https://doi.org/10.2337/diacare.22.7.1029
    2. A prospective study of risk factors for diabetic foot ulcer. The Seattle Diabetic Foot Study.
      E J Boyko, J H Ahroni, V Stensel, R C Forsberg, D R Davignon and D G Smith
      Diabetes Care 1999 Jul; 22 (7): 1036-1042. https://doi.org/10.2337/diacare.22.7.1036

  14. Smits, P

    1. Prevalence of "syndrome X" features in parents of type 1 diabetic patients with or without nephropathy.
      B Verhage, G Vervoort, C Wolkotte, L D Elving, J F Wetzels, H Willems, P Smits, A L Verbeek and J H Berden
      Diabetes Care 1999 Jul; 22 (7): 1048-1052. https://doi.org/10.2337/diacare.22.7.1048

  15. Snorgaard, O

    1. Serum levels of advanced glycation end products are associated with left ventricular diastolic function in patients with type 1 diabetes.
      T J Berg, O Snorgaard, J Faber, P A Torjesen, P Hildebrandt, J Mehlsen and K F Hanssen
      Diabetes Care 1999 Jul; 22 (7): 1186-1190. https://doi.org/10.2337/diacare.22.7.1186

  16. Steffes, M W

    1. Increased small dense LDL and intermediate-density lipoprotein with albuminuria in type 1 diabetes.
      S D Sibley, J E Hokanson, M W Steffes, J Q Purnell, S M Marcovina, P A Cleary and J D Brunzell
      Diabetes Care 1999 Jul; 22 (7): 1165-1170. https://doi.org/10.2337/diacare.22.7.1165

  17. Stehouwer, C D

    1. Leptin and variables of body adiposity, energy balance, and insulin resistance in a population-based study. The Hoorn Study.
      J B Ruige, J M Dekker, W F Blum, C D Stehouwer, G Nijpels, J Mooy, P J Kostense, L M Bouter and R J Heine
      Diabetes Care 1999 Jul; 22 (7): 1097-1104. https://doi.org/10.2337/diacare.22.7.1097

  18. Stensel, V

    1. A prospective study of risk factors for diabetic foot ulcer. The Seattle Diabetic Foot Study.
      E J Boyko, J H Ahroni, V Stensel, R C Forsberg, D R Davignon and D G Smith
      Diabetes Care 1999 Jul; 22 (7): 1036-1042. https://doi.org/10.2337/diacare.22.7.1036

  19. Suzuki, S

    1. Determining an episode of care using claims data. Diabetic foot ulcer.
      S S Mehta, S Suzuki, H A Glick and K A Schulman
      Diabetes Care 1999 Jul; 22 (7): 1110-1115. https://doi.org/10.2337/diacare.22.7.1110

  20. Svanström, L

    1. Low birth weight, family history of diabetes, and glucose intolerance in Swedish middle-aged men.
      S Carlsson, P G Persson, M Alvarsson, S Efendic, A Norman, L Svanström, C G Ostenson and V Grill
      Diabetes Care 1999 Jul; 22 (7): 1043-1047. https://doi.org/10.2337/diacare.22.7.1043

T

  1. Takatsuka, N

    1. Depressive symptoms and occurrence of type 2 diabetes among Japanese men.
      N Kawakami, N Takatsuka, H Shimizu and H Ishibashi
      Diabetes Care 1999 Jul; 22 (7): 1071-1076. https://doi.org/10.2337/diacare.22.7.1071

  2. Teramo, K A

    1. What is the significance of macrosomia?
      R Schwartz and K A Teramo
      Diabetes Care 1999 Jul; 22 (7): 1201-1205. https://doi.org/10.2337/diacare.22.7.1201

  3. Thon, A

    1. Circadian blood pressure during the early course of type 1 diabetes. Analysis of 1,011 ambulatory blood pressure recordings in 354 adolescents and young adults.
      R W Holl, M Pavlovic, E Heinze and A Thon
      Diabetes Care 1999 Jul; 22 (7): 1151-1157. https://doi.org/10.2337/diacare.22.7.1151

  4. Toft-Nielsen, M B

    1. Continuous subcutaneous infusion of glucagon-like peptide 1 lowers plasma glucose and reduces appetite in type 2 diabetic patients.
      M B Toft-Nielsen, S Madsbad and J J Holst
      Diabetes Care 1999 Jul; 22 (7): 1137-1143. https://doi.org/10.2337/diacare.22.7.1137

  5. Toki, Y

    1. Low-density lipoprotein particle size as an independent predictor of glycated low-density lipoprotein level.
      H Matsui, K Okumura, Y Toki and T Hayakawa
      Diabetes Care 1999 Jul; 22 (7): 1220-1221. https://doi.org/10.2337/diacare.22.7.1220a

  6. Tominaga, Y

    1. Insulin resistance and classic risk factors in type 2 diabetic patients with different subtypes of ischemic stroke.
      K Matsumoto, S Miyake, M Yano, Y Ueki, A Miyazaki, K Hirao and Y Tominaga
      Diabetes Care 1999 Jul; 22 (7): 1191-1195. https://doi.org/10.2337/diacare.22.7.1191

  7. Torella, R

    1. Aminotransferase activity and acarbose treatment in patients with type 2 diabetes.
      S Gentile, S Turco, G Guarino, F C Sasso and R Torella
      Diabetes Care 1999 Jul; 22 (7): 1217-1218. https://doi.org/10.2337/diacare.22.7.1217

  8. Torjesen, P A

    1. Serum levels of advanced glycation end products are associated with left ventricular diastolic function in patients with type 1 diabetes.
      T J Berg, O Snorgaard, J Faber, P A Torjesen, P Hildebrandt, J Mehlsen and K F Hanssen
      Diabetes Care 1999 Jul; 22 (7): 1186-1190. https://doi.org/10.2337/diacare.22.7.1186

  9. Tritschler, H

    1. alpha-Tocopherol induces leptin expression in healthy individuals and in vitro.
      B Isermann, A Bierhaus, H Tritschler, R Ziegler and P P Nawroth
      Diabetes Care 1999 Jul; 22 (7): 1227-1228. https://doi.org/10.2337/diacare.22.7.1227a

  10. Tsai, J H

    1. Increased urinary atrial natriuretic peptide-like immunoreactivity excretion but decreased plasma atrial natriuretic peptide concentration in patients with hyperosmolar-hyperglycemic nonketotic syndrome.
      S J Shin, Y J Lee, P J Hsiao and J H Tsai
      Diabetes Care 1999 Jul; 22 (7): 1181-1185. https://doi.org/10.2337/diacare.22.7.1181

  11. Tsui, E Y

    1. Cultural adaptation of the diabetes quality-of-life measure for Chinese patients.
      A Y Cheng, E Y Tsui, A J Hanley and B Zinman
      Diabetes Care 1999 Jul; 22 (7): 1216-1217. https://doi.org/10.2337/diacare.22.7.1216

  12. Tumini, S

    1. Increased Na+/Li+ countertransport activity may help to identify type 1 diabetic adolescents and young adults at risk for developing persistent microalbuminuria.
      F Chiarelli, M Catino, S Tumini, M de Martino, A Mezzetti, A Verrotti and M Vanelli
      Diabetes Care 1999 Jul; 22 (7): 1158-1164. https://doi.org/10.2337/diacare.22.7.1158

  13. Tuomilehto, J

    1. The onset age of type 1 diabetes in Finnish children has become younger. The Finnish Childhood Diabetes Registry Group.
      M Karvonen, J Pitkäniemi and J Tuomilehto
      Diabetes Care 1999 Jul; 22 (7): 1066-1070. https://doi.org/10.2337/diacare.22.7.1066

  14. Tuominen, J T

    1. Bone mineral density in patients with type 1 and type 2 diabetes.
      J T Tuominen, O Impivaara, P Puukka and T Rönnemaa
      Diabetes Care 1999 Jul; 22 (7): 1196-1200. https://doi.org/10.2337/diacare.22.7.1196

  15. Turco, S

    1. Aminotransferase activity and acarbose treatment in patients with type 2 diabetes.
      S Gentile, S Turco, G Guarino, F C Sasso and R Torella
      Diabetes Care 1999 Jul; 22 (7): 1217-1218. https://doi.org/10.2337/diacare.22.7.1217

U

  1. Uchimura, K

    1. Hypersensitivity to regular and intermediate, but not to crystallized, insulin as an aggravation factor for underlying bulimia nervosa in a patient with type 1 diabetes.
      M Itoh, K Uchimura, M Makino, T Kobayashi, H Kakizawa, M Nagata, K Fujiwara, S Kato, Y Itoh and A Nagasaka
      Diabetes Care 1999 Jul; 22 (7): 1221-1224. https://doi.org/10.2337/diacare.22.7.1221

  2. Ueki, Y

    1. Insulin resistance and classic risk factors in type 2 diabetic patients with different subtypes of ischemic stroke.
      K Matsumoto, S Miyake, M Yano, Y Ueki, A Miyazaki, K Hirao and Y Tominaga
      Diabetes Care 1999 Jul; 22 (7): 1191-1195. https://doi.org/10.2337/diacare.22.7.1191

V

  1. Vanelli, M

    1. Increased Na+/Li+ countertransport activity may help to identify type 1 diabetic adolescents and young adults at risk for developing persistent microalbuminuria.
      F Chiarelli, M Catino, S Tumini, M de Martino, A Mezzetti, A Verrotti and M Vanelli
      Diabetes Care 1999 Jul; 22 (7): 1158-1164. https://doi.org/10.2337/diacare.22.7.1158

  2. Verbeek, A L

    1. Prevalence of "syndrome X" features in parents of type 1 diabetic patients with or without nephropathy.
      B Verhage, G Vervoort, C Wolkotte, L D Elving, J F Wetzels, H Willems, P Smits, A L Verbeek and J H Berden
      Diabetes Care 1999 Jul; 22 (7): 1048-1052. https://doi.org/10.2337/diacare.22.7.1048

  3. Verhage, B

    1. Prevalence of "syndrome X" features in parents of type 1 diabetic patients with or without nephropathy.
      B Verhage, G Vervoort, C Wolkotte, L D Elving, J F Wetzels, H Willems, P Smits, A L Verbeek and J H Berden
      Diabetes Care 1999 Jul; 22 (7): 1048-1052. https://doi.org/10.2337/diacare.22.7.1048

  4. Verrotti, A

    1. Increased Na+/Li+ countertransport activity may help to identify type 1 diabetic adolescents and young adults at risk for developing persistent microalbuminuria.
      F Chiarelli, M Catino, S Tumini, M de Martino, A Mezzetti, A Verrotti and M Vanelli
      Diabetes Care 1999 Jul; 22 (7): 1158-1164. https://doi.org/10.2337/diacare.22.7.1158

  5. Vervoort, G

    1. Prevalence of "syndrome X" features in parents of type 1 diabetic patients with or without nephropathy.
      B Verhage, G Vervoort, C Wolkotte, L D Elving, J F Wetzels, H Willems, P Smits, A L Verbeek and J H Berden
      Diabetes Care 1999 Jul; 22 (7): 1048-1052. https://doi.org/10.2337/diacare.22.7.1048

  6. Vølund, A

    1. Previous maternal abortion, longer gestation, and younger maternal age decrease the risk of type 1 diabetes among male offspring.
      I Bache, T Bock, A Vølund and K Buschard
      Diabetes Care 1999 Jul; 22 (7): 1063-1065. https://doi.org/10.2337/diacare.22.7.1063

W

  1. Weinger, K

    1. Blood glucose awareness training and epinephrine responses to hypoglycemia during intensive treatment in type 1 diabetes.
      B T Kinsley, K Weinger, M Bajaj, C J Levy, D C Simonson, M Quigley, D J Cox and A M Jacobson
      Diabetes Care 1999 Jul; 22 (7): 1022-1028. https://doi.org/10.2337/diacare.22.7.1022

  2. Wetzels, J F

    1. Prevalence of "syndrome X" features in parents of type 1 diabetic patients with or without nephropathy.
      B Verhage, G Vervoort, C Wolkotte, L D Elving, J F Wetzels, H Willems, P Smits, A L Verbeek and J H Berden
      Diabetes Care 1999 Jul; 22 (7): 1048-1052. https://doi.org/10.2337/diacare.22.7.1048

  3. Whitecotton, L

    1. Work disability and diabetes.
      J A Mayfield, P Deb and L Whitecotton
      Diabetes Care 1999 Jul; 22 (7): 1105-1109. https://doi.org/10.2337/diacare.22.7.1105

  4. Willems, H

    1. Prevalence of "syndrome X" features in parents of type 1 diabetic patients with or without nephropathy.
      B Verhage, G Vervoort, C Wolkotte, L D Elving, J F Wetzels, H Willems, P Smits, A L Verbeek and J H Berden
      Diabetes Care 1999 Jul; 22 (7): 1048-1052. https://doi.org/10.2337/diacare.22.7.1048

  5. Williams, K V

    1. Improved glycemic control reduces the impact of weight gain on cardiovascular risk factors in type 1 diabetes. The Epidemiology of Diabetes Complications Study.
      K V Williams, J R Erbey, D Becker and T J Orchard
      Diabetes Care 1999 Jul; 22 (7): 1084-1091. https://doi.org/10.2337/diacare.22.7.1084

  6. Wolkotte, C

    1. Prevalence of "syndrome X" features in parents of type 1 diabetic patients with or without nephropathy.
      B Verhage, G Vervoort, C Wolkotte, L D Elving, J F Wetzels, H Willems, P Smits, A L Verbeek and J H Berden
      Diabetes Care 1999 Jul; 22 (7): 1048-1052. https://doi.org/10.2337/diacare.22.7.1048

Y

  1. Yano, M

    1. Insulin resistance and classic risk factors in type 2 diabetic patients with different subtypes of ischemic stroke.
      K Matsumoto, S Miyake, M Yano, Y Ueki, A Miyazaki, K Hirao and Y Tominaga
      Diabetes Care 1999 Jul; 22 (7): 1191-1195. https://doi.org/10.2337/diacare.22.7.1191

  2. Yoshino, G

    1. Increased urinary transferrin excretion predicts microalbuminuria in patients with type 2 diabetes.
      T Kazumi, T Hozumi, Y Ishida, Y Ikeda, K Kishi, M Hayakawa and G Yoshino
      Diabetes Care 1999 Jul; 22 (7): 1176-1180. https://doi.org/10.2337/diacare.22.7.1176

Z

  1. Zawacki, C M

    1. Is pregnancy in diabetic women associated with folate deficiency?
      J S Kaplan, S Iqbal, B G England, C M Zawacki and W H Herman
      Diabetes Care 1999 Jul; 22 (7): 1017-1021. https://doi.org/10.2337/diacare.22.7.1017

  2. Ziegler, R

    1. alpha-Tocopherol induces leptin expression in healthy individuals and in vitro.
      B Isermann, A Bierhaus, H Tritschler, R Ziegler and P P Nawroth
      Diabetes Care 1999 Jul; 22 (7): 1227-1228. https://doi.org/10.2337/diacare.22.7.1227a

  3. Zimmet, P

    1. Is fasting leptin associated with insulin resistance among nondiabetic individuals? The Miami Community Health Study.
      R P Donahue, R J Prineas, R D Donahue, P Zimmet, J A Bean, M De Courten, G Collier, R B Goldberg, J S Skyler and N Schneiderman
      Diabetes Care 1999 Jul; 22 (7): 1092-1096. https://doi.org/10.2337/diacare.22.7.1092

  4. Zinman, B

    1. Cultural adaptation of the diabetes quality-of-life measure for Chinese patients.
      A Y Cheng, E Y Tsui, A J Hanley and B Zinman
      Diabetes Care 1999 Jul; 22 (7): 1216-1217. https://doi.org/10.2337/diacare.22.7.1216
Back to top